The positive effects were confirmed later by Gong and colleagues, who constructed a MALAT1-specific ASO that reduced the MALAT1 expression levels, decreased the migration ability in lung cancer cells, and significantly reduced the metastatic tumor nodule formation in vivo [319]. Here, MALAT1 is linked to lung cancer.